Reni Benjamin
Stock Analyst at Citizens JMP
(0.06)
# 4,669
Out of 4,696 analysts
793
Total ratings
35.2%
Success rate
-8.7%
Average return
Main Sectors:
Stocks Rated by Reni Benjamin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IOVA Iovance Biotherapeutics | Maintained: Buy | $5 → $8 | $8.62 | -7.19% | 50 | Aug 7, 2026 | |
| ONC BeOne Medicines AG | Maintained: Buy | $396 → $405 | $361.78 | +11.95% | 11 | Aug 6, 2026 | |
| STRO Sutro Biopharma | Maintained: Buy | $35 → $41 | $20.47 | +100.29% | 47 | Apr 23, 2026 | |
| WHWK Whitehawk Therapeutics | Initiated Coverage: Buy | $8 | $4.71 | +69.85% | 1 | Apr 16, 2026 | |
| ALLO Allogene Therapeutics | Maintained: Buy | $5 → $8 | $1.98 | +304.04% | 36 | Apr 14, 2026 | |
| BCYC Bicycle Therapeutics | Maintained: Buy | $12 → $8 | $4.30 | +86.05% | 37 | Mar 18, 2026 | |
| IMMP Immutep | Downgraded: Hold | n/a | $0.3829 | - | 2 | Mar 13, 2026 | |
| PRLD Prelude Therapeutics | Maintained: Buy | $3 → $6 | $5.43 | +10.50% | 15 | Mar 11, 2026 | |
| LYEL Lyell Immunopharma | Initiated Coverage: Buy | $34 | $14.96 | +127.35% | 1 | Mar 9, 2026 | |
| IMMX Immix Biopharma | Initiated Coverage: Buy | $23 | $13.96 | +64.76% | 1 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $31 | $23.56 | +31.58% | 1 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.9983 | - | 12 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $31.05 | +3.06% | 1 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $2.43 | +311.52% | 1 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $8 | $3.89 | +105.66% | 16 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.35 | - | 28 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $13.11 | +83.07% | 41 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $128.83 | - | 105 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $14.60 | +173.97% | 8 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $7.69 | n/a | 7 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $124.97 | n/a | 6 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $26.96 | n/a | 27 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.63 | n/a | 10 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.35 | n/a | 12 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0008 | n/a | 12 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $8.02 | n/a | 20 | May 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $6 | $0.021 | n/a | 19 | May 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.32 | n/a | 24 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $110 | $66.97 | n/a | 1 | Apr 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $5 | $1.11 | n/a | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $73 → $57 | $44.42 | n/a | 14 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $96 → $94 | $9.60 | n/a | 12 | Feb 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $0.9803 | n/a | 4 | Dec 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $5 | $1.67 | n/a | 25 | Nov 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $3.54 | n/a | 9 | Nov 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $10 | $9.51 | n/a | 17 | Oct 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $13 | $1.68 | n/a | 16 | Aug 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $56.90 | n/a | 25 | Aug 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.2798 | n/a | 8 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.45 | n/a | 21 | Aug 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $7.95 | n/a | 14 | Aug 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $14.16 | n/a | 10 | Dec 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.0354 | n/a | 7 | Jun 4, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $0.0021 | n/a | 1 | May 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.56 | n/a | 7 | May 21, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 5 | May 15, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $3 | $2.36 | n/a | 5 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $5 | $1.13 | n/a | 6 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $12 | $9.89 | n/a | 7 | Mar 19, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.42 | n/a | 4 | Feb 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $8.09 | n/a | 6 | Jan 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $0.00001 | n/a | 6 | Dec 11, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.99 | n/a | 3 | Oct 13, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $36.93 | n/a | 1 | May 5, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $39 | $23.21 | n/a | 1 | Jul 24, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $1.59 | n/a | 2 | Oct 12, 2010 |
Iovance Biotherapeutics
Aug 7, 2026
Maintained: Buy
Price Target: $5 → $8
Current: $8.62
Upside: -7.19%
BeOne Medicines AG
Aug 6, 2026
Maintained: Buy
Price Target: $396 → $405
Current: $361.78
Upside: +11.95%
Sutro Biopharma
Apr 23, 2026
Maintained: Buy
Price Target: $35 → $41
Current: $20.47
Upside: +100.29%
Whitehawk Therapeutics
Apr 16, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $4.71
Upside: +69.85%
Allogene Therapeutics
Apr 14, 2026
Maintained: Buy
Price Target: $5 → $8
Current: $1.98
Upside: +304.04%
Bicycle Therapeutics
Mar 18, 2026
Maintained: Buy
Price Target: $12 → $8
Current: $4.30
Upside: +86.05%
Immutep
Mar 13, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.3829
Upside: -
Prelude Therapeutics
Mar 11, 2026
Maintained: Buy
Price Target: $3 → $6
Current: $5.43
Upside: +10.50%
Lyell Immunopharma
Mar 9, 2026
Initiated Coverage: Buy
Price Target: $34
Current: $14.96
Upside: +127.35%
Immix Biopharma
Mar 9, 2026
Initiated Coverage: Buy
Price Target: $23
Current: $13.96
Upside: +64.76%
Jan 29, 2026
Initiated Coverage: Buy
Price Target: $31
Current: $23.56
Upside: +31.58%
Dec 19, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.9983
Upside: -
Dec 3, 2025
Initiated Coverage: Buy
Price Target: $32
Current: $31.05
Upside: +3.06%
Dec 3, 2025
Initiated Coverage: Buy
Price Target: $10
Current: $2.43
Upside: +311.52%
Oct 30, 2025
Maintained: Buy
Price Target: $5 → $8
Current: $3.89
Upside: +105.66%
Oct 8, 2025
Reiterated: Hold
Price Target: n/a
Current: $9.35
Upside: -
Sep 30, 2025
Reiterated: Buy
Price Target: $24
Current: $13.11
Upside: +83.07%
Sep 18, 2025
Reiterated: Hold
Price Target: n/a
Current: $128.83
Upside: -
Sep 8, 2025
Reiterated: Buy
Price Target: $40
Current: $14.60
Upside: +173.97%
Aug 15, 2025
Reiterated: Hold
Price Target: n/a
Current: $7.69
Upside: n/a
May 15, 2025
Maintained: Hold
Price Target: n/a
Current: $124.97
Upside: n/a
Apr 21, 2025
Reiterated: Buy
Price Target: $2
Current: $26.96
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $2.63
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $7.35
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $0.0008
Upside: n/a
May 10, 2019
Downgraded: Hold
Price Target: n/a
Current: $8.02
Upside: n/a
May 7, 2019
Reiterated: Buy
Price Target: $16 → $6
Current: $0.021
Upside: n/a
May 2, 2019
Maintained: Hold
Price Target: n/a
Current: $4.32
Upside: n/a
Apr 9, 2019
Initiated Coverage: Buy
Price Target: $110
Current: $66.97
Upside: n/a
Mar 18, 2019
Maintained: Buy
Price Target: $6 → $5
Current: $1.11
Upside: n/a
Mar 1, 2019
Maintained: Buy
Price Target: $73 → $57
Current: $44.42
Upside: n/a
Feb 5, 2019
Upgraded: Buy
Price Target: $96 → $94
Current: $9.60
Upside: n/a
Dec 13, 2018
Maintained: Buy
Price Target: $21
Current: $0.9803
Upside: n/a
Nov 15, 2018
Upgraded: Buy
Price Target: $5
Current: $1.67
Upside: n/a
Nov 14, 2018
Upgraded: Buy
Price Target: n/a
Current: $3.54
Upside: n/a
Oct 12, 2018
Maintained: Buy
Price Target: $11 → $10
Current: $9.51
Upside: n/a
Aug 28, 2018
Maintained: Buy
Price Target: $13 → $13
Current: $1.68
Upside: n/a
Aug 14, 2018
Maintained: Buy
Price Target: $22
Current: $56.90
Upside: n/a
Aug 10, 2018
Maintained: Hold
Price Target: n/a
Current: $0.2798
Upside: n/a
Aug 7, 2018
Maintained: Hold
Price Target: n/a
Current: $2.45
Upside: n/a
Aug 7, 2018
Maintained: Hold
Price Target: n/a
Current: $7.95
Upside: n/a
Dec 18, 2017
Rated: Hold
Price Target: n/a
Current: $14.16
Upside: n/a
Jun 4, 2015
Reiterated: Buy
Price Target: $6
Current: $0.0354
Upside: n/a
May 26, 2015
Initiated Coverage: Buy
Price Target: $13
Current: $0.0021
Upside: n/a
May 21, 2015
Maintained: Buy
Price Target: $8
Current: $1.56
Upside: n/a
May 15, 2015
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Mar 31, 2015
Reiterated: Buy
Price Target: $7 → $3
Current: $2.36
Upside: n/a
Mar 31, 2015
Reiterated: Buy
Price Target: $9 → $5
Current: $1.13
Upside: n/a
Mar 19, 2015
Reiterated: Buy
Price Target: $8 → $12
Current: $9.89
Upside: n/a
Feb 18, 2015
Reiterated: Buy
Price Target: $4
Current: $1.42
Upside: n/a
Jan 9, 2015
Reiterated: Buy
Price Target: $6
Current: $8.09
Upside: n/a
Dec 11, 2014
Maintained: Buy
Price Target: $40
Current: $0.00001
Upside: n/a
Oct 13, 2014
Maintained: Hold
Price Target: n/a
Current: $1.99
Upside: n/a
May 5, 2014
Initiated Coverage: Buy
Price Target: $17
Current: $36.93
Upside: n/a
Jul 24, 2013
Downgraded: Hold
Price Target: $39
Current: $23.21
Upside: n/a
Oct 12, 2010
Reiterated: Buy
Price Target: $9
Current: $1.59
Upside: n/a